SCHEMBL14023294

SCHEMBL14023294

CCc1ccc(-c2ccc([C@@H](OC)[C@@H](CF)N=[N+]=[N-])cc2)cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14022478 0.91 PIK3CD (0.38) —
SCHEMBL13527559 0.91 PIK3CA (0.33) —
SCHEMBL20026322 0.87 MAOB (0.32) —
SCHEMBL13527562 0.87 MAOB (0.32) —
SCHEMBL13527622 0.86 — —
SCHEMBL13527577 0.86 MKNK1 (0.38) —
SCHEMBL14022480 0.86 LTA4H (0.34) —
SCHEMBL20026167 0.86 — —
SCHEMBL14082446 0.86 AKR1C3 (0.34) —
SCHEMBL14083251 0.85 HDAC1 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008143730-A2 MACROLIDE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME RIB-X PHARMACEUTICALS, INC. (US) 2008-11-27 — — WO disclosed
Send feedback